Skip to main content

Post MI: ACE inhibitor or ARB therapy

CBE ID
0594
1.4 Project
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

This measure identifies patients with ST elevation MI (STEMI), or non-ST elevation MI (NSTEMI) plus a history of hypertension, heart failure and/or diabetes prior to the measurement year who are taking an ACEI or an ARB during the measurement year.

        • 1.14 Numerator

          Patients in the denominator with at least 1 Rx claim for an ACEI or an ARB medication during the measurement year

          Time Window: See below

        • 1.15 Denominator

          Patients with STEMI, or NSTEMI with hypertension, HF and/or diabetes, prior to the measurement year

          Tine Window: See below

        • Exclusions

          Excludes members who meet the following criteria for the ACE/ARB contraindication
          - >=1 claim with a diagnosis code for ´hyperkalemia´, ´renal artery stenosis´, ´ESRD´, ´severe chronic kidney disease´, ´pregnancy´, or ´angioneurotic edema´ (see below for the complete list of ICD9 codes)´

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Cardiovascular Project 2014-2015
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          Resolution Health, Inc.
          Steward Organization POC Email